微创根治性前列腺切除术后出血的当代管理
回顾性分析2010年1月至2017年1月在本机构接受微创根治性前列腺切除术的3749例患者,其中4%(151/3749)发生临床显著出血;仅0.32%(12/3749)需二次手术止血。大多数出血患者无需输血即可稳定,轻度出血者额外医疗资源使用率约为无出血者的两倍。
要点
- 临床显著出血定义为血红蛋白较术前下降≥30%或4 g/dL、30天内输血或二次手术止血。
- 3749例中4%(151/3749)发生临床显著出血,1.6%(60/3749)接受输血,0.32%(12/3749)行二次手术止血。
- 30天复合结局(急诊就诊、再入院或Grade≥3并发症)在仅监测组为25%、输血组为65%、二次手术组为100%,无出血的3598例中为12.5%。
核心结论
- 大多数发生临床显著出血的患者无需输血即可稳定,仅极少数需二次干预。
- 发生较轻出血事件的患者使用额外医疗资源的比率约为无出血者的两倍,作者认为需给予适当咨询和术后监测。
研究设计与样本
- 回顾性分析2010年1月至2017年1月在本机构接受微创根治性前列腺切除术的患者数据。
- 共纳入3749例男性,按处理方式分为3组:仅连续监测组、接受输血组、接受二次手术组。
主要发现
- 3749例中4%(151/3749)发生临床显著出血,1.6%(60/3749)接受输血,0.32%(12/3749)接受二次手术止血。
- 30天复合结局(急诊就诊、再入院或Grade≥3并发症)发生率:仅监测组25%,输血组65%,二次手术组100%;无出血的3598例中为12.5%。
- 接受二次手术者术后1年勃起功能最差;3组排尿功能结局相似。
关键数值与推荐
- 临床显著出血定义为血红蛋白从术前至术后4或14小时下降≥30%或4 g/dL,或30天内接受输血,或接受二次手术控制出血。
临床怎么用
- 作者认为,发生较轻出血事件的患者使用额外医疗资源的比率约为无出血者的两倍,需给予适当咨询和术后监测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe contemporary management and outcomes of patients experiencing postoperative hemorrhage after minimally invasive radical prostatectomy. MATERIALS AND METHODS: We retrospectively analyzed data from patients who underwent minimally invasive radical prostatectomy at our institution between January 2010 and January 2017. Clinically significant hemorrhage was defined as a decrease in hemoglobin of ≥30% or 4 g/dL from preoperative to 4 or 14 hours postoperative measurement, receiving a blood transfusion within 30 days, or undergoing a secondary procedure to control bleeding. Patients were analyzed in 3 groups: (1) serially monitored only, (2) received a blood transfusion, and (3) underwent a secondary procedure. Outcomes included imaging studies performed, length of stay, emergency room visits, hospital readmissions, complication rates, and functional outcomes. RESULTS: Of 3749 men, 4% (151/3749) had clinically significant hemorrhage, 1.6% (60/3749) received a transfusion; 0.32% (12/3749) underwent a secondary procedure to control bleeding. In a 30-day composite outcome, increased healthcare utilization (emergency room visit, readmission, or Grade ≥3 complications), was seen in 25% of the serial monitoring group, 65% of the transfusion group, and 100% in the secondary procedure group. This rate in 3598 men without hemorrhage was 12.5%. One-year erectile function was poorest in men who underwent a secondary procedure. Urinary functional outcomes were similar in the 3 groups. CONCLUSION: Most patients experiencing clinically significant hemorrhage will stabilize without transfusion, and a very small fraction require secondary intervention. Patients experiencing milder bleeding events utilized additional healthcare resources at approximately twice the rate of those who did not, warranting appropriate counseling and postoperative monitoring.
引用
- Dean LW, Tin AL, Chesnut GT, et al. Contemporary Management of Hemorrhage After Minimally Invasive Radical Prostatectomy. Urology. 2019. PMID: 31034916. doi:10.1016/j.urology.2019.04.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。